Centro Hospitalar de Trás-os-Montes e Alto Douro, EPE

Vila Real 5000-508

1 studies enrolling now · 4 studies all time

What they study most

Alpha 1-Antitrypsin Deficiency, Breast Cancer, Urothelial Cancer

Studies at this site

• A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence — Recruiting now
• A Study of Belcesiran in Patients With AATLD — Stopped early
• Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04] — Running, not enrolling
• A Study Of Avelumab In Patients With Locally Advanced Or Metastatic Urothelial Cancer (JAVELIN Bladder 100) — Completed